Quick Connect Send a message
Shanghai, June 26, 2025 —Dr. Reddy’s Laboratories’ Active Pharmaceutical Ingredients (API) business made a dynamic appearance at CPHI China 2025, held at the Shanghai New International Expo Center from June 24–26.
Held at the Shanghai New International Expo Center, the event gave us the opportunity to connect with formulation partners, regulatory experts, and innovators from around the world. We proudly presented our portfolio of 250+ APIs, spanning oncology, cardiology, pain management, and more each backed by rigorous science and global regulatory compliance. Our team, led by Deepak Sapra and Nirav Shah, engaged in meaningful conversations around early market entry strategies, complex API development, and sustainable manufacturing practices. We were especially excited to share our progress on ESG goals and our recognition in global sustainability indices.
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.
+91 4049002253